Ashleigh Brown
Psychiatric/Mental Health · Jacksonville, NCNPI 1972931061
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 379 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Vanda Pharmaceuticals Inc. at 29.3% of the total. Among psychiatric/mental health clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 379 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$2K
- Supernus Pharmaceuticals, Inc.$705
- AbbVie$583
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$512
- Teva Pharmaceuticals USA, Inc.$468
- Otsuka America Pharmaceutical, Inc.$405
- plus $2K from 14 others
What the payments were for
- Food & beverage$6,666100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 93 | $1,956 |
| Supernus Pharmaceuticals, Inc. | 50 | $705 |
| AbbVie | 38 | $583 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $512 |
| Teva Pharmaceuticals USA, Inc. | 27 | $468 |
| Otsuka America Pharmaceutical, Inc. | 25 | $405 |
| Lundbeck LLC | 18 | $345 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $338 |
| Johnson & Johnson | 8 | $243 |
| Ironshore Pharmaceuticals Inc. | 14 | $237 |
| Axsome Therapeutics, Inc. | 12 | $210 |
| Alkermes, Inc. | 12 | $207 |
| Eisai Inc. | 15 | $161 |
| Corium, LLC | 7 | $104 |
| Idorsia Pharmaceuticals US Inc | 3 | $52 |
| Almatica Pharma LLC | 2 | $35 |
| Neos Therapeutics, LP | 2 | $34 |
| Sunovion Pharmaceuticals Inc. | 2 | $31 |
| Neurocrine Biosciences, Inc. | 2 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
How this compares
$6,675 in reported general payments places this provider in the 90th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 17 | $240 |
| Clonazepam | 17 | $67 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Jacksonville
- Pamela EdwardsJacksonville$16K
- Melvin JamesJacksonville$14K
- Nicole DunniganJacksonville$8K
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.